SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus
Titel:
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus
Auteur:
Hess, David A. Terenzi, Daniella C. Trac, Justin Z. Quan, Adrian Mason, Tamique Al-Omran, Mohammed Bhatt, Deepak L. Dhingra, Natasha Rotstein, Ori D. Leiter, Lawrence A. Zinman, Bernard Sabongui, Sandra Yan, Andrew T. Teoh, Hwee Mazer, C. David Connelly, Kim A. Verma, Subodh